Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Pre-eclampsia.Lancet. 2010; 376: 631-644
- ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia.Obstet Gynecol. 2019; 133: e1-e25
- Maternal mortality: who, when, where, and why.Lancet. 2006; 368: 1189-1200
- WHO analysis of causes of maternal death: a systematic review.Lancet. 2006; 367: 1066-1074
- The Global Impact of Pre-eclampsia and Eclampsia.Semin Perinatol. 2009; 33: 130-137
- An assessment of pregnancy-related mortality in the United States.Paediatr Perinat Epidemiol. 2005; 19: 206-214
- Preeclampsia: the role of angiogenic factors in its pathogenesis.Physiology (Bethesda). 2009; 24: 147-158
- Short-term costs of preeclampsia to the United States health care system.Am J Obstet Gynecol. 2017; 217: 237-248 e216
- Meeting the challenges of measuring and preventing maternal mortality in the United States. Public Health Grand Rounds.(Available at:) (Accessed June 6, 2022)
- Reducing disparities in severe maternal morbidity and mortality.Clin Obstet Gynecol. 2018; 61: 387-399
- Williams obstetrics.24th edition. McGraw-Hill Education, New York2014
- The two stage model of preeclampsia: variations on the theme.Placenta. 2009; 30: S32-S37
- Trophoblast deportation and the maternal inflammatory response in pre-eclampsia.J Reprod Immunol. 2003; 59: 153-160
- Eicosanoids in preeclampsia.Prostaglandins Leukot Essent Fatty Acids. 2004; 70: 223-232
- Preeclampsia: an imbalance in placental prostacyclin and thromboxane production.Am J Obstet Gynecol. 1985; 152: 335-340
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls.N Engl J Med. 1979; 300: 1142-1147
- Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: A multicenter prospective study.J Am Med Assoc. 1999; 282: 356-362
Bdolah Y, Sukhatme VP, Karumanchi SA. Angiogenic imbalance in the pathophysiology of preeclampsia: Newer insights. In: Seminars in Nephrology. ; 2004.
- Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.N Engl J Med. 2016; 374: 13-22
- Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1/PlGF Ratio in Singleton Pregnancies.Fetal Diagn Ther. 2018; 43: 81-89
- Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.N Engl J Med. 2006; 355: 992-1005
- Pathophysiology of ischemic placental disease.Semin Perinatol. 2014; 38: 139-145
- Aspirin for prevention of preeclampsia.Drugs. 2017; 77: 1819-1831
- Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.Nat New Biol. 1971; 231: 232-235
- Molecular Mechanisms Regulating the Vascular Prostacyclin Pathways and Their Adaptation during Pregnancy and in the Newborn.Pharmacol Rev. 2012; 64: 540-582
- Molecular mechanism of thromboxane A2-induced platelet aggregation.J Biol Chem. 1999; 274: 29108-29114
- A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.Postgrad Med. 2015; 127: 573-580
- Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK/AP-1 pathway in human trophoblast and endothelial cells.J Cell Physiol. 2019; 234: 18928-18941
- Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1.Placenta. 2015; 36: 446-453
- Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects.Thromb Res. 1980; 17: 317-327
- Low-dose aspirin increases 15-epi-lipoxins A4 in pregnancies at high-risk for developing preeclampsia.Pregnancy Hypertens. 2021; 26: 75-78
- Effect of aspirin on incidence of preeclampsia.Lancet. 1979; 1: 1356
- Low-dose aspirin to prevent preeclampsia in women at high risk.N Engl J Med. 1998; 338: 701-705
- CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women.Lancet. 1994; 343: 619-629
- Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women.N Engl J Med. 1993; 329: 1213-1218
- Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.Am J Obstet Gynecol. 2018; 218: 287-293.e1
- Antiplatelet therapy before or after 16 weeks’ gestation for preventing preeclampsia: an individual participant data meta-analysis.Am J Obstet Gynecol. 2017; 216: 121-128.e2
- The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.Am J Obstet Gynecol. 2017; 216: 110-120.e6
- ASPRE trial: performance of screening for preterm pre-eclampsia.Ultrasound Obstet Gynecol. 2017; 50: 492-495
- Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation.Ultrasound Obstet Gynecol. 2017; 50: 551-556
- First-trimester prediction of hypertensive disorders in pregnancy.Hypertension. 2009; 53: 812-818
- American college of obstetricians and gynecologists. first-trimester risk assessment for early-onset preeclampsia.Obstet Gynecol. 2015; 126: e25-e27
- Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia.N Engl J Med. 2017; 377: 613-622
- Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2014; 161: 819-826
- Gestational hypertension and preeclampsia.Obstet Gynecol. 2019; 133: 1
- Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the us preventive services task force.JAMA. 2021; 326: 1192-1206
- A nudge toward universal aspirin for preeclampsia prevention.Obstet Gynecol. 2019; 133: 725-728
- A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States.Obstet Gynecol. 2015; 126: 1242-1250
- Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 1).BJOG. 2003; 110: 475-484
- Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.Br J Obstet Gynaecol. 1998; 105: 286-292
- Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. preventive services task force.Ann Intern Med. 2014; 160: 695-703
- Antiplatelet agents for preventing pre-eclampsia and its complications.Cochrane Database Syst Rev. 2007; 2: CD004659
- Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage.Am J Obstet Gynecol. 2018; 218: 483-489
- Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: american society of regional anesthesia and pain medicine evidence-based guidelines (4th edition).Reg Anesth Pain Med. 2018; 43: 263-309
- Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia.Curr Mol Pharmacol. 2016; 10: 152-160
- Structural mechanism for statin inhibition of HMG-CoA reductase.Science. 2001; 292: 1160-1164
- Pravastatin for preventing and treating preeclampsia: a systematic review.Obstet Gynecol Surv. 2018; 73: 40-55
- Transplacental transfer and distribution of pravastatin.Am J Obstet Gynecol. 2013; 209: e1-e5
- Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model.Proc Natl Acad Sci. 2010; 108: 1451-1455
- Using pravastatin to improve the vascular reactivity in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia.Obstet Gynecol. 2010; 116: 114-120
- Pravastatin to treat and prevent preeclampsia. Preclinical and clinical studies.J Reprod Immunol. 2017; 124: 15-20
- Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension.Hypertension. 2013; 61: 1103-1110
- Clinical Improvement and Successful Pregnancy in a Preeclamptic Patient With Antiphospholipid Syndrome Treated With Pravastatin.Hypertension. 2014; 63: e118-e119
- Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.J Clin Invest. 2016; 126: 2933-2940
- Effects of Pravastatin on Human Placenta, Endothelium, and Women with Severe Preeclampsia.Hypertension. 2015; 66: 687-697
- Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: A pilot randomized controlled trial.Am J Obstet Gynecol. 2016; 214: e1-e17
- Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.J Matern Fetal Neonatal Med. 2021; : 1-7https://doi.org/10.1080/14767058.2021.1940940
- INOVASIA study: a multicenter randomized clinical trial of pravastatin to prevent preeclampsia in high-risk patients.Am J Perinatol. 2022; ([published online ahead of print, 2022 Jun 6])https://doi.org/10.1055/a-1798-1925
- Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia.Circulation. 2021; 144: 670-679
- Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.Eur Heart J. 2018; 39: 2526-2539
- Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.Cardiovasc Drugs Ther. 2005; 19: 403-414
- The risks of statin use in pregnancy: A systematic review.J Clin Lipidol. 2016; 10: 1081-1090
- Statins and congenital malformations: cohort study.BMJ. 2015; 350: h1035
- FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins.(Available at:) (Accessed June 29, 2022)
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
